First	O
report	O
of	O
Toxoplasma	B-OG
gondii	I-OG
in	O
camels	B-OG
(	O
Camelus	B-OG
dromedarius	I-OG
)	O
in	O
Ethiopia	O
:	O
bioassay	O
and	O
seroepidemiological	O
investigation	O

Background	O

Toxoplasmosis	B-DS
is	O
a	O
major	O
public	O
health	O
concern	O
in	O
many	O
countries	O
of	O
the	O
world	O
.	O

A	O
cross	O
-	O
sectional	O
and	O
follow	O
up	O
experimental	O
study	O
designs	O
were	O
used	O
for	O
seroepidemiological	O
and	O
bioassay	O
studies	O
,	O
respectively	O
from	O
November	O
2012	O
to	O
April	O
2013	O
.	O

The	O
objectives	O
were	O
to	O
estimate	O
the	O
seroprevalence	O
of	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
,	O
to	O
assess	O
risk	O
factors	O
and	O
to	O
isolate	O
the	O
parasite	O
from	O
camels	B-OG
in	O
the	O
Fentale	O
district	O
,	O
Ethiopia	O
.	O

A	O
direct	O
agglutination	O
test	O
(	O
DAT	O
)	O
and	O
indirect	O
enzyme	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
kits	O
were	O
used	O
to	O
test	O
camel	B-OG
sera	O
.	O

Hearts	O
and	O
tongues	O
(	O
each	O
25	O
g	O
)	O
from	O
31	O
seropositive	O
camels	B-OG
were	O
bioassayed	O
in	O
mice	B-OG
.	O

Associations	O
between	O
seroprevalence	O
and	O
potential	O
risk	O
factors	O
(	O
collected	O
using	O
a	O
questionnaire	O
survey	O
)	O
were	O
analyzed	O
using	O
logistic	O
regression	O
.	O

Results	O

An	O
overall	O
T	B-OG
.	I-OG
gondii	I-OG
prevalence	O
of	O
49	O
.	O
62	O
%	O
(	O
220	O
/	O
455	O
)	O
by	O
DAT	O
and	O
40	O
.	O
49	O
%	O
(	O
179	O
/	O
451	O
)	O
by	O
indirect	O
ELISA	O
test	O
were	O
detected	O
.	O

Herd	O
level	O
seroprevalence	O
of	O
96	O
.	O
77	O
%	O
(	O
30	O
/	O
31	O
)	O
(	O
95	O
%	O
CI	O
:	O
83	O
.	O
30	O
–	O
99	O
.	O
92	O
)	O
by	O
DAT	O
was	O
recorded	O
and	O
it	O
was	O
significantly	O
higher	O
in	O
areas	O
where	O
wild	O
felids	B-OG
are	O
present	O
(	O
P	O
=	O
0	O
.	O
038	O
).	O

Multivariable	O
logistic	O
regression	O
showed	O
that	O
the	O
likelihood	O
of	O
acquiring	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
was	O
significantly	O
higher	O
in	O
camels	B-OG
in	O
the	O
Ilala	O
pastoral	O
association	O
[	O
PA	O
]	O
(	O
82	O
.	O
26	O
%)	O
(	O
Adjusted	O
Odds	O
ratio	O
[	O
aOR	O
]	O
=	O
10	O
.	O
8	O
;	O
P	O
<	O
0	O
.	O
001	O
)	O
than	O
camels	B-OG
in	O
the	O
Galcha	O
PA	O
(	O
31	O
.	O
43	O
%),	O
in	O
camels	B-OG
of	O
≥	O
8	O
years	O
old	O
(	O
56	O
.	O
52	O
%;	O
aOR	O
=	O
1	O
.	O
88	O
;	O
P	O
=	O
0	O
,	O
033	O
)	O
than	O
camels	B-OG
of	O
≤	O
4	O
years	O
old	O
(	O
34	O
.	O
26	O
%)	O
and	O
in	O
areas	O
where	O
domestic	O
cats	B-OG
are	O
present	O
(	O
aOR	O
=	O
4	O
.	O
16	O
;	O
P	O
=	O
0	O
.	O
006	O
).	O

All	O
camel	B-OG
owners	O
were	O
uneducated	O
,	O
handle	O
aborted	O
fetus	O
with	O
bare	O
hands	O
,	O
and	O
drink	O
raw	O
camel	B-OG
milk	O
.	O

DAT	O
and	O
ELISA	O
tests	O
had	O
moderate	O
agreement	O
(	O
Kappa	O
=	O
0	O
.	O
41	O
).	O

Viable	O
T	B-OG
.	I-OG
gondii	I-OG
were	O
isolated	O
from	O
16	O
.	O
13	O
%	O
(	O
5	O
/	O
31	O
)	O
of	O
DAT	O
positive	O
camels	B-OG
.	O

One	O
DAT	O
positive	O
but	O
ELISA	O
negative	O
camel	B-OG
sample	O
gave	O
a	O
cyst	B-DS
positive	O
result	O
.	O

Conclusions	O

T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
of	O
camels	B-OG
in	O
the	O
study	O
district	O
is	O
widespread	O
.	O

Age	O
,	O
presence	O
of	O
domestic	O
cats	B-OG
and	O
study	O
PA	O
are	O
independent	O
predictors	O
of	O
T	B-OG
.	I-OG
gondii	I-OG
seropositivity	O
.	O

Isolation	O
of	O
viable	O
parasites	O
from	O
edible	O
tissues	O
of	O
camels	B-OG
and	O
the	O
very	O
poor	O
knowledge	O
of	O
pastoralists	O
about	O
toxoplasmosis	B-DS
suggest	O
the	O
need	O
for	O
prevention	O
of	O
toxoplasmosis	B-DS
through	O
bio	O
-	O
security	O
measures	O
,	O
education	O
and	O
further	O
investigation	O
to	O
unravel	O
the	O
impact	O
of	O
camel	B-OG
toxoplasmosis	B-DS
deserves	O
consideration	O
.	O

Electronic	O
supplementary	O
material	O

The	O
online	O
version	O
of	O
this	O
article	O
(	O
doi	O
:	O
10	O
.	O
1186	O
/	O
s12917	O
-	O
014	O
-	O
0222	O
-	O
7	O
)	O
contains	O
supplementary	O
material	O
,	O
which	O
is	O
available	O
to	O
authorized	O
users	O
.	O

Background	O

A	O
population	O
over	O
2	O
.	O
3	O
million	O
camels	B-OG
is	O
estimated	O
in	O
Ethiopia	O
[	O
1	O
],	O
which	O
is	O
considered	O
the	O
third	O
largest	O
camel	B-OG
populated	O
country	O
in	O
the	O
world	O
.	O

All	O
camels	B-OG
in	O
Ethiopia	O
are	O
owned	O
by	O
pastoralists	O
[	O
2	O
].	O

Camels	B-OG
play	O
a	O
central	O
role	O
in	O
the	O
livelihood	O
of	O
pastoralists	O
through	O
provision	O
of	O
milk	O
,	O
meat	O
,	O
and	O
draught	O
power	O
and	O
they	O
also	O
determine	O
their	O
wealth	O
and	O
social	O
status	O
[	O
3	O
].	O

Despite	O
their	O
social	O
,	O
ecological	O
and	O
economic	O
importance	O
in	O
Ethiopia	O
,	O
until	O
recently	O
they	O
were	O
neglected	O
by	O
researchers	O
and	O
development	O
planners	O
and	O
as	O
a	O
result	O
little	O
is	O
known	O
about	O
productivity	O
and	O
health	O
problems	O
in	O
camels	B-OG
compared	O
to	O
other	O
livestock	O
[	O
4	O
,	O
5	O
].	O

Camels	B-OG
suffer	O
from	O
various	O
parasitic	B-DS
diseases	I-DS
,	O
including	O
toxoplasmosis	B-DS
,	O
which	O
have	O
public	O
health	O
and	O
economic	O
importance	O
[	O
6	O
].	O

Toxoplasmosis	B-DS
is	O
caused	O
by	O
an	O
intracellular	O
Apicomplexa	B-OG
protozoan	O
,	O
T	B-OG
.	I-OG
gondii	I-OG
,	O
found	O
worldwide	O
and	O
in	O
an	O
exceptionally	O
broad	O
host	O
range	O
on	O
earth	O
[	O
7	O
].	O

Camels	B-OG
acquire	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
through	O
ingestion	O
or	O
inhalation	O
of	O
sporulated	O
oocysts	O
that	O
are	O
shed	O
by	O
cats	B-OG
or	O
wild	O
felids	B-OG
in	O
the	O
environment	O
[	O
8	O
].	O
The	O
prevalence	O
of	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
in	O
camels	B-OG
varies	O
widely	O
depending	O
on	O
the	O
localities	O
of	O
the	O
world	O
[	O
9	O
],	O
ranging	O
from	O
3	O
.	O
12	O
%	O
in	O
Iran	O
[	O
10	O
]	O
to	O
90	O
.	O
90	O
%	O
in	O
Turkey	O
[	O
11	O
].	O

T	B-OG
.	I-OG
gondii	I-OG
infects	O
one	O
-	O
third	O
of	O
the	O
world	O
human	B-OG
population	O
.	O

The	O
infection	B-DS
can	O
be	O
life	O
threatening	O
during	O
pregnancy	O
and	O
in	O
immunocompromised	O
individuals	O
[	O
12	O
,	O
13	O
].	O

The	O
disease	O
is	O
a	O
major	O
public	O
health	O
concern	O
in	O
many	O
countries	O
of	O
the	O
world	O
[	O
14	O
].	O

In	O
USA	O
,	O
it	O
is	O
the	O
third	O
leading	O
cause	O
of	O
death	O
from	O
foodborne	O
diseases	O
[	O
12	O
].	O

Humans	B-OG
become	O
infected	O
with	O
T	B-OG
.	I-OG
gondii	I-OG
mostly	O
by	O
ingesting	O
raw	O
or	O
undercooked	O
meat	O
of	O
infected	O
animals	B-OG
or	O
by	O
ingesting	O
food	O
or	O
water	O
contaminated	O
with	O
oocysts	O
[	O
13	O
]	O
and	O
the	O
parasite	O
can	O
be	O
transmitted	O
to	O
the	O
fetus	O
by	O
the	O
passage	O
of	O
tachyzoites	O
through	O
the	O
placenta	O
[	O
15	O
].	O

The	O
presence	O
of	O
T	B-OG
.	I-OG
gondii	I-OG
in	O
milk	O
[	O
10	O
]	O
and	O
edible	O
tissues	O
[	O
16	O
]	O
of	O
carrier	O
camels	B-OG
indicate	O
the	O
possibility	O
of	O
transmission	O
to	O
humans	B-OG
;	O
particularly	O
in	O
pastoral	O
communities	O
in	O
which	O
raw	O
milk	O
,	O
and	O
to	O
some	O
extent	O
raw	O
meat	O
,	O
can	O
be	O
frequently	O
consumed	O
[	O
17	O
].	O

Recent	O
reports	O
from	O
Ethiopia	O
indicate	O
high	O
seroprevalence	O
of	O
toxoplasmosis	B-DS
in	O
women	B-OG
of	O
child	O
-	O
bearing	O
age	O
ranging	O
from	O
70	O
.	O
29	O
to	O
87	O
.	O
4	O
%	O
[	O
18	O
-	O
20	O
].	O

Studies	O
done	O
in	O
different	O
parts	O
of	O
Ethiopia	O
over	O
the	O
last	O
24	O
years	O
indicated	O
high	O
seroprevalence	O
of	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
in	O
sheep	B-OG
[	O
21	O
-	O
23	O
],	O
goats	B-OG
[	O
21	O
,	O
22	O
,	O
24	O
,	O
25	O
],	O
cattle	B-OG
[	O
21	O
],	O
chicken	B-OG
[	O
26	O
]	O
and	O
cats	B-OG
[	O
27	O
].	O

However	O
,	O
there	O
is	O
no	O
single	O
report	O
of	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
in	O
Ethiopian	O
camels	B-OG
so	O
far	O
.	O

Although	O
DAT	O
and	O
ELISA	O
tests	O
have	O
been	O
widely	O
used	O
for	O
detection	O
of	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
in	O
epidemiological	O
studies	O
,	O
there	O
are	O
no	O
reports	O
on	O
the	O
comparative	O
evaluation	O
of	O
the	O
diagnostic	O
capability	O
of	O
these	O
diagnostic	O
tests	O
in	O
naturally	O
infected	O
camels	B-OG
.	O

This	O
report	O
compares	O
serodiagnostic	O
methods	O
of	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
in	O
camels	B-OG
using	O
commercial	O
kits	O
(	O
DAT	O
and	O
ELISA	O
),	O
and	O
isolation	O
of	O
the	O
parasite	O
from	O
edible	O
camel	B-OG
tissues	O
,	O
to	O
estimate	O
the	O
seroprevalence	O
of	O
toxoplasmosis	B-DS
in	O
camels	B-OG
.	O

The	O
role	O
of	O
the	O
identified	O
risk	O
factors	O
on	O
the	O
parasite	O
transmission	O
is	O
also	O
discussed	O
.	O

Methods	O

Study	O
area	O
and	O
study	O
animals	B-OG

The	O
study	O
was	O
conducted	O
in	O
the	O
Fentale	O
district	O
(	O
39	O
.	O
93	O
°	O
E	O
to	O
39	O
°	O
56	O
’	O
0	O
”	O
E	O
longitude	O
and	O
8	O
.	O
975o	O
N	O
to	O
8	O
.	O
58	O
’	O
30	O
”	O
N	O
latitude	O
)	O
which	O
is	O
located	O
in	O
the	O
East	O
Shewa	O
Zone	O
of	O
Oromia	O
Regional	O
State	O
,	O
Ethiopia	O
(	O
Figure	O
1	O
)	O
at	O
190	O
Kms	O
East	O
of	O
Addis	O
Ababa	O
.	O

It	O
lies	O
at	O
an	O
altitude	O
range	O
of	O
955	O
-	O
2007	O
meters	O
above	O
sea	O
level	O
,	O
and	O
has	O
an	O
annual	O
rainfall	O
ranging	O
from	O
560	O
millimeter	O
(	O
mm	O
)	O
to	O
630	O
mm	O
and	O
mean	O
temperature	O
ranging	O
from	O
29	O
°	O
C	O
to	O
38	O
°	O
C	O
.	O

The	O
vegetation	O
comprises	O
mix	O
of	O
acacia	B-OG
trees	I-OG
,	O
bushes	B-OG
and	O
shrubs	B-OG
that	O
are	O
common	O
to	O
the	O
lowland	O
areas	O
of	O
Ethiopia	O
.	O

With	O
its	O
arid	O
and	O
semi	O
-	O
arid	O
climate	O
,	O
pastoral	O
and	O
agro	O
-	O
pastoral	O
production	O
systems	O
predominate	O
in	O
the	O
area	O
.	O

The	O
district	O
is	O
estimated	O
to	O
possess	O
48	O
,	O
078	O
camels	B-OG
found	O
in	O
eighteen	O
pastoral	O
associations	O
(	O
PAs	O
).	O

Pastoral	O
and	O
agro	O
-	O
pastoral	O
production	O
systems	O
are	O
practiced	O
in	O
11	O
and	O
7	O
PAs	O
,	O
respectively	O
[	O
28	O
].	O
Figure	O
1Map	O
of	O
the	O
Fentale	O
district	O
showing	O
sampled	O
pastoral	O
associations	O
(	O
PAs	O
)	O
(	O
adapted	O
from	O
https	O
://	O
www	O
.	O
google	O
.	O
com	O
.	O
et	O
/	O
search	O
?	O
q	O
=	O
Ethiopia	O
+	O
map	O
&	O
btnG	O
=&	O
tbm	O
=	O
isch	O
&	O
gws_rd	O
=	O
ssl	O
).	O

The	O
study	O
population	O
consisted	O
of	O
camels	B-OG
of	O
different	O
age	O
groups	O
in	O
selected	O
PAs	O
of	O
the	O
district	O
managed	O
under	O
the	O
two	O
production	O
systems	O
.	O

The	O
camels	B-OG
of	O
both	O
sex	O
groups	O
were	O
classified	O
by	O
age	O
into	O
three	O
categories	O
(≤	O
4	O
years	O
,	O
4	O
-	O
8	O
years	O
and	O
>	O
8	O
years	O
)	O
[	O
29	O
].	O

Ages	O
of	O
camels	B-OG
were	O
recorded	O
based	O
on	O
information	O
from	O
the	O
owners	O
and	O
also	O
estimated	O
according	O
to	O
their	O
dentations	O
[	O
30	O
].	O

Study	O
design	O
,	O
sample	O
size	O
determination	O
and	O
sampling	O
method	O

Cross	O
-	O
sectional	O
and	O
follow	O
up	O
experimental	O
study	O
designs	O
were	O
used	O
for	O
seroepidemiological	O
and	O
bioassay	O
studies	O
,	O
respectively	O
from	O
November	O
2012	O
to	O
April	O
2013	O
.	O

Out	O
of	O
18	O
PAs	O
,	O
a	O
total	O
of	O
6	O
PAs	O
(	O
pastoral	O
=	O
3	O
,	O
agro	O
-	O
pastoral	O
=	O
3	O
)	O
were	O
chosen	O
conveniently	O
based	O
on	O
accessibility	O
of	O
the	O
PAs	O
.	O

Camel	B-OG
herds	O
in	O
each	O
of	O
the	O
selected	O
PAs	O
were	O
stratified	O
by	O
herd	O
size	O
into	O
three	O
:	O
small	O
(	O
1	O
-	O
9	O
),	O
medium	O
(	O
10	O
-	O
19	O
)	O
and	O
large	O
(≥	O
20	O
)	O
camels	B-OG
[	O
31	O
].	O

Out	O
of	O
58	O
camel	B-OG
herds	O
found	O
in	O
the	O
selected	O
study	O
PAs	O
(	O
n	O
=	O
6	O
),	O
31	O
herds	O
were	O
randomly	O
selected	O
using	O
the	O
lottery	O
method	O
.	O

Then	O
,	O
all	O
camels	B-OG
in	O
selected	O
herds	O
were	O
used	O
to	O
collect	O
blood	O
samples	O
.	O

Since	O
there	O
has	O
been	O
no	O
previous	O
study	O
on	O
camel	B-OG
toxoplasmosis	B-DS
in	O
Ethiopia	O
,	O
50	O
%	O
expected	O
prevalence	O
(	O
P	O
)	O
and	O
95	O
%	O
confidence	O
interval	O
(	O
Z	O
=	O
1	O
.	O
96	O
)	O
with	O
a	O
5	O
%	O
desired	O
absolute	O
precision	O
(	O
d	O
)	O
was	O
considered	O
to	O
arrive	O
at	O
the	O
required	O
sample	O
size	O
(	O
n	O
=	O
384	O
)	O
for	O
the	O
seroepidemiological	O
study	O
using	O
the	O
formula	O
:	O
n	O
=	O
P	O
(	O
1	O
-	O
P	O
)	O
Z2	O
/	O
d2	O
)	O
[	O
32	O
].	O

Additionally	O
,	O
purposive	O
sampling	O
of	O
blood	O
from	O
70	O
camels	B-OG
was	O
considered	O
for	O
sample	O
selection	O
by	O
serology	O
in	O
order	O
to	O
use	O
their	O
heart	O
and	O
tongue	O
for	O
bioassay	O
.	O

Sample	O
collection	O
and	O
transportation	O

Blood	O
samples	O
for	O
serum	O
separation	O
were	O
collected	O
from	O
the	O
jugular	O
vein	O
of	O
apparently	O
healthy	O
camels	B-OG
using	O
labeled	O
plain	O
vacutainer	O
tubes	O
following	O
proper	O
physical	O
restraining	O
.	O

For	O
the	O
bioassay	O
,	O
heart	O
,	O
tongue	O
and	O
blood	O
sample	O
of	O
purposively	O
selected	O
70	O
camels	B-OG
,	O
originating	O
from	O
Fentale	O
district	O
but	O
slaughtered	O
at	O
Akaki	O
abattoir	O
near	O
Addis	O
Ababa	O
,	O
were	O
collected	O
.	O

The	O
collected	O
samples	O
were	O
kept	O
in	O
an	O
icebox	O
containing	O
ice	O
packs	O
and	O
immediately	O
transported	O
to	O
the	O
Ethio	O
-	O
Belgium	O
post	O
-	O
graduate	O
research	O
laboratory	O
,	O
College	O
of	O
Veterinary	O
Medicine	O
and	O
Agriculture	O
,	O
Debre	O
Zeit	O
,	O
Ethiopia	O
for	O
serological	O
testing	O
and	O
isolation	O
of	O
T	B-OG
.	I-OG
gondii	I-OG
.	O

Sera	O
were	O
separated	O
by	O
centrifugation	O
at	O
3200	O
rpm	O
for	O
10	O
minutes	O
,	O
decanted	O
into	O
cryovials	O
and	O
stored	O
at	O
-	O
20	O
°	O
C	O
until	O
used	O
for	O
serological	O
assay	O
.	O

Heart	O
and	O
tongue	O
samples	O
were	O
kept	O
at	O
+	O
4	O
°	O
C	O
for	O
1	O
-	O
3	O
days	O
until	O
serological	O
results	O
were	O
known	O
.	O

Questionnaire	O
survey	O

A	O
close	O
-	O
ended	O
questionnaire	O
was	O
designed	O
and	O
self	O
-	O
administered	O
to	O
collect	O
data	O
about	O
the	O
potential	O
risk	O
factors	O
for	O
camels	B-OG
to	O
acquire	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
.	O

Awareness	O
of	O
camel	B-OG
owners	O
about	O
toxoplasmosis	B-DS
including	O
the	O
habits	O
of	O
consumption	O
of	O
raw	O
camel	B-OG
meat	O
and	O
milk	O
was	O
also	O
documented	O
.	O

The	O
questions	O
in	O
the	O
questionnaire	O
included	O
sex	O
(	O
male	O
,	O
female	O
),	O
age	O
(≤	O
4	O
years	O
,	O
4	O
-	O
8	O
years	O
and	O
>	O
8	O
years	O
),	O
production	O
system	O
(	O
pastoral	O
/	O
agropastoral	O
),	O
presence	O
of	O
cats	B-OG
(	O
yes	O
/	O
no	O
),	O
presence	O
of	O
wild	O
felids	B-OG
(	O
yes	O
/	O
no	O
),	O
source	O
of	O
drinking	O
water	O
(	O
tap	O
,	O
stagnant	O
:	O
[	O
lake	O
,	O
pond	O
and	O
well	O
],	O
river	O
,	O
mixed	O
[	O
river	O
and	O
stagnant	O
])	O
and	O
herd	O
size	O
(	O
small	O
:	O
1	O
-	O
9	O
,	O
medium	O
:	O
10	O
-	O
19	O
,	O
large	O
:	O
≥	O
20	O
camels	B-OG
)	O
[	O
31	O
].	O

Information	O
about	O
history	O
of	O
abortion	O
(	O
yes	O
/	O
no	O
),	O
way	O
of	O
handling	O
aborted	O
fetus	O
(	O
wearing	O
gloves	O
,	O
without	O
wearing	O
glove	O
,	O
washing	O
hand	O
after	O
handling	O
,	O
without	O
washing	O
hand	O
after	O
handling	O
)	O
and	O
method	O
of	O
disposal	O
of	O
aborted	O
fetus	O
(	O
giving	O
to	O
cat	B-OG
,	O
throwing	O
along	O
the	O
way	O
,	O
burying	O
)	O
were	O
recorded	O
.	O

Moreover	O
,	O
camel	B-OG
owners	O
consumption	O
habits	O
of	O
camel	B-OG
meat	O
(	O
cooking	O
,	O
without	O
cooking	O
,	O
both	O
)	O
and	O
raw	O
milk	O
consumption	O
(	O
yes	O
/	O
no	O
),	O
educational	O
level	O
(	O
uneducated	O
,	O
primary	O
school	O
,	O
secondary	O
school	O
,	O
tertiary	O
/	O
university	O
)	O
and	O
awareness	O
about	O
:	O
toxoplasmosis	B-DS
(	O
yes	O
/	O
no	O
),	O
role	O
of	O
cat	B-OG
to	O
transmit	O
diseases	O
to	O
owner	O
(	O
yes	O
/	O
no	O
),	O
role	O
of	O
cat	B-OG
to	O
transmit	O
diseases	O
to	O
camel	B-OG
(	O
yes	O
/	O
no	O
)	O
and	O
camel	B-OG
migration	O
(	O
yes	O
/	O
no	O
)	O
and	O
routes	O
of	O
migration	O
were	O
also	O
gathered	O
.	O

Laboratory	O
investigation	O

Direct	O
agglutination	O
test	O
(	O
DAT	O
)	O

All	O
sera	O
samples	O
collected	O
were	O
examined	O
for	O
the	O
presence	O
of	O
antibodies	B-GP
(	O
IgG	B-GP
)	O
against	O
T	B-OG
.	I-OG
gondii	I-OG
by	O
the	O
direct	O
agglutination	O
test	O
(	O
Toxo	O
screen	O
DA	O
,	O
biomerieux	O
®,	O
France	O
)	O
following	O
the	O
protocol	O
of	O
the	O
manufacturer	O
.	O

The	O
kit	O
was	O
claimed	O
by	O
the	O
manufacturer	O
to	O
have	O
sensitivity	O
and	O
specificity	O
of	O
96	O
.	O
22	O
%	O
and	O
98	O
.	O
80	O
%,	O
respectively	O
.	O

Sera	O
were	O
assayed	O
at	O
a	O
screening	O
dilution	O
of	O
1	O
:	O
40	O
and	O
1	O
:	O
4000	O
.	O

A	O
titer	O
of	O
1	O
:	O
40	O
or	O
1	O
:	O
4000	O
or	O
both	O
was	O
considered	O
indicative	O
of	O
T	B-OG
.	I-OG
gondii	I-OG
exposure	O
.	O

Sedimentation	O
of	O
antigen	O
at	O
the	O
bottom	O
of	O
the	O
well	O
and	O
clear	O
agglutination	O
above	O
half	O
of	O
the	O
well	O
at	O
either	O
dilution	O
were	O
recorded	O
as	O
negative	O
and	O
positive	O
results	O
respectively	O
.	O

DAT	O
positive	O
samples	O
were	O
titrated	O
to	O
know	O
the	O
endpoint	O
titer	O
.	O

Positive	O
and	O
negative	O
controls	O
were	O
included	O
in	O
each	O
test	O
.	O

Indirect	O
enzyme	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O

A	O
total	O
of	O
451	O
(	O
381	O
from	O
field	O
and	O
70	O
from	O
abattoir	O
)	O
sera	O
were	O
tested	O
for	O
T	B-OG
.	I-OG
gondii	I-OG
IgG	B-GP
antibodies	I-GP
by	O
the	O
indirect	O
ELISA	O
kit	O
(	O
ID	O
VET	O
Innovative	O
Diagnostic	O
,	O
ID	O
Screen	O
®,	O
Montpellier	O
,	O
France	O
)	O
following	O
the	O
manufacturer	O
’	O
s	O
instructions	O
.	O

The	O
wells	O
of	O
the	O
kit	O
are	O
coated	O
with	O
T	B-OG
.	I-OG
gondii	I-OG
P30	B-GP
(	O
SAG1	B-GP
)	O
surface	O
antigen	O
.	O

The	O
kit	O
uses	O
non	O
-	O
species	O
specific	O
protein	O
conjugate	O
that	O
is	O
used	O
in	O
several	O
animal	B-OG
species	O
.	O

For	O
interpretation	O
of	O
the	O
result	O
S	O
/	O
P	O
%	O
was	O
calculated	O
as	O
:	O
S	O
/	O
P	O
%	O
=	O
(	O
optical	O
density	O
[	O
OD	O
]	O
450	O
value	O
of	O
the	O
sample	O
–	O
OD	O
450	O
value	O
of	O
the	O
negative	O
control	O
)/(	O
mean	O
OD	O
450	O
value	O
of	O
the	O
positive	O
control	O
–	O
OD	O
450	O
value	O
of	O
the	O
negative	O
control	O
)	O
×	O
100	O
.	O

Any	O
sample	O
with	O
S	O
/	O
P	O
%	O
≤	O
40	O
%,	O
40	O
%	O
-	O
50	O
%	O
and	O
≥	O
50	O
%	O
were	O
considered	O
as	O
negative	O
,	O
doubtful	O
and	O
positive	O
,	O
respectively	O
.	O

With	O
this	O
cut	O
-	O
off	O
the	O
manufacturer	O
claims	O
the	O
test	O
to	O
have	O
more	O
than	O
99	O
%	O
specificity	O
and	O
sensitivity	O
.	O

The	O
test	O
was	O
considered	O
valid	O
if	O
the	O
mean	O
OD	O
value	O
of	O
the	O
positive	O
control	O
(	O
ODPC	O
)	O
is	O
greater	O
than	O
0	O
.	O
350	O
(	O
ODPC	O
>	O
0	O
.	O
350	O
)	O
and	O
the	O
ratio	O
of	O
the	O
mean	O
OD	O
value	O
of	O
the	O
positive	O
and	O
negative	O
controls	O
(	O
ODPC	O
and	O
ODNC	O
)	O
is	O
greater	O
than	O
3	O
.	O
5	O
(	O
ODPC	O
/	O
ODNC	O
>	O
3	O
.	O
5	O
).	O

The	O
doubtful	O
sera	O
were	O
retested	O
.	O

Bioassay	O

Heart	O
and	O
tongue	O
tissue	O
samples	O
(	O
pooled	O
weight	O
50	O
g	O
)	O
from	O
DAT	O
positive	O
camels	B-OG
(	O
n	O
=	O
31	O
)	O
slaughtered	O
at	O
Akaki	O
abattoir	O
,	O
were	O
processed	O
for	O
isolation	O
of	O
T	B-OG
.	I-OG
gondii	I-OG
as	O
described	O
previously	O
[	O
13	O
].	O

Briefly	O
,	O
each	O
sample	O
was	O
cut	O
into	O
small	O
pieces	O
,	O
homogenized	O
in	O
a	O
blender	O
for	O
30	O
seconds	O
,	O
followed	O
by	O
soaking	O
in	O
125	O
ml	O
of	O
saline	O
solution	O
for	O
another	O
30	O
seconds	O
(	O
0	O
.	O
14	O
M	O
sodium	O
chloride	O
).	O

After	O
homogenization	O
250	O
ml	O
of	O
pepsin	B-GP
solution	O
(	O
Merck	O
KG	O
.	O
A	O
,	O
Darmstadt	O
,	O
Germany	O
)	O
was	O
added	O
(	O
pH	O
=	O
1	O
.	O
1	O
–	O
1	O
.	O
2	O
)	O
and	O
incubated	O
at	O
37	O
°	O
C	O
for	O
1	O
h	O
.	O

The	O
homogenate	O
was	O
filtered	O
through	O
two	O
layers	O
of	O
gauze	O
and	O
centrifuged	O
at	O
3200	O
rpm	O
for	O
10	O
minutes	O
.	O

The	O
supernatant	O
was	O
discarded	O
and	O
to	O
the	O
sediment	O
15	O
to	O
20	O
ml	O
of	O
1	O
.	O
2	O
%	O
sodium	O
bicarbonate	O
(	O
pH	O
=	O
8	O
.	O
3	O
)	O
was	O
added	O
and	O
centrifuged	O
at	O
3200	O
rpm	O
for	O
10	O
min	O
.	O

The	O
supernatant	O
was	O
discarded	O
and	O
the	O
sediment	O
was	O
re	O
-	O
suspended	O
in	O
5	O
to	O
10	O
ml	O
of	O
antibiotic	O
saline	O
solution	O
(	O
1000	O
U	O
/	O
ml	O
penicillin	O
and	O
100	O
μg	O
of	O
streptomycin	O
/	O
ml	O
of	O
saline	O
solution	O
).	O

The	O
suspension	O
was	O
inoculated	O
intraperitoneally	O
(	O
1	O
ml	O
per	O
mouse	B-OG
)	O
into	O
five	O
apparently	O
healthy	O
T	B-OG
.	I-OG
gondii	I-OG
seronegative	O
female	O
Swiss	B-OG
-	I-OG
Albino	I-OG
mice	I-OG
(	O
National	O
Veterinary	O
Institute	O
,	O
Debre	O
Zeit	O
)	O
per	O
sample	O
(	O
weighting	O
25	O
–	O
35	O
g	O
)	O
as	O
described	O
by	O
Dubey	O
[	O
13	O
].	O

Bioassays	O
were	O
performed	O
within	O
1	O
-	O
3	O
days	O
of	O
the	O
slaughter	O
of	O
the	O
camels	B-OG
.	O

Separate	O
knives	O
,	O
cutting	O
boards	O
,	O
gloves	O
,	O
plastic	O
cups	O
/	O
falcon	O
tubes	O
,	O
and	O
plastic	O
bags	O
for	O
blending	O
and	O
pepsin	B-GP
digestion	O
were	O
used	O
for	O
each	O
sample	O
to	O
avoid	O
contamination	O
among	O
samples	O
.	O

Tissue	O
homogenate	O
kept	O
in	O
6	O
falcon	O
tubes	O
(	O
50	O
ml	O
)	O
were	O
centrifuged	O
in	O
2	O
steps	O
;	O
the	O
first	O
and	O
second	O
batch	O
in	O
4	O
and	O
2	O
floating	O
buckets	O
of	O
the	O
centrifuge	O
.	O

Approximately	O
110	O
-	O
140	O
minutes	O
elapsed	O
from	O
the	O
time	O
the	O
tissue	O
was	O
homogenized	O
in	O
saline	O
to	O
the	O
time	O
the	O
material	O
was	O
pulled	O
into	O
syringes	O
for	O
mouse	B-OG
inoculation	O
.	O

The	O
inoculated	O
mice	B-OG
were	O
observed	O
daily	O
for	O
illness	O
for	O
60	O
days	O
and	O
information	O
on	O
number	O
of	O
survivors	O
,	O
dead	O
,	O
day	O
of	O
death	O
,	O
symptoms	O
,	O
and	O
weight	O
(	O
initial	O
and	O
final	O
)	O
were	O
recorded	O
.	O

The	O
mice	B-OG
were	O
fed	O
with	O
pelleted	O
feed	O
and	O
municipal	O
chlorinated	O
water	O
ad	O
-	O
libitum	O
.	O
T	B-OG
.	I-OG
gondii	I-OG
isolate	O
was	O
considered	O
as	O
virulent	O
if	O
100	O
%	O
mortality	O
of	O
mouse	B-OG
was	O
observed	O
within	O
four	O
weeks	O
of	O
infection	B-DS
[	O
33	O
].	O

Surviving	O
mice	B-OG
were	O
bled	O
on	O
day	O
60	O
after	O
anesthetizing	O
with	O
di	O
-	O
ethyl	O
ether	O
(	O
Biolab	O
laboratories	O
ltd	O
,	O
Israel	O
).	O

Brains	O
of	O
all	O
mice	B-OG
were	O
removed	O
by	O
sagittal	O
dissection	O
and	O
then	O
examined	O
for	O
tissue	O
cysts	B-DS
.	O

The	O
inoculated	O
mice	B-OG
were	O
considered	O
infected	O
with	O
T	B-OG
.	I-OG
gondii	I-OG
when	O
tissue	O
cysts	B-DS
were	O
found	O
in	O
brain	O
tissues	O
and	O
/	O
or	O
the	O
sera	O
of	O
mice	B-OG
react	O
positively	O
for	O
the	O
commercial	O
DAT	O
.	O

The	O
brain	O
was	O
homogenized	O
in	O
1	O
ml	O
phosphate	O
buffer	O
saline	O
(	O
PBS	O
)	O
by	O
using	O
a	O
mortar	O
and	O
pestle	O
.	O

The	O
numbers	O
of	O
cysts	B-DS
in	O
five	O
aliquots	O
of	O
each	O
10	O
μl	O
were	O
counted	O
under	O
microscope	O
with	O
a	O
10	O
×	O
and	O
40	O
×	O
objective	O
lens	O
and	O
summed	O
.	O

The	O
total	O
number	O
of	O
cysts	B-DS
in	O
the	O
brain	O
of	O
each	O
mouse	B-OG
was	O
determined	O
by	O
multiplying	O
the	O
number	O
of	O
cysts	B-DS
in	O
the	O
50	O
μl	O
sample	O
examined	O
with	O
the	O
dilution	O
factor	O
[	O
34	O
].	O

Data	O
management	O
and	O
analyses	O

The	O
data	O
generated	O
from	O
field	O
and	O
laboratory	O
investigations	O
were	O
entered	O
and	O
coded	O
using	O
Microsoft	O
Excel	O
®	O
2007	O
and	O
analyzed	O
using	O
STATA	O
version	O
11	O
.	O
0	O
for	O
Windows	O
(	O
Stata	O
Corp	O
.	O

College	O
Station	O
,	O
TX	O
,	O
USA	O
).	O

Descriptive	O
statistic	O
was	O
used	O
to	O
summarize	O
the	O
data	O
.	O

The	O
information	O
from	O
the	O
questionnaire	O
survey	O
was	O
used	O
to	O
define	O
explanatory	O
variables	O
to	O
be	O
tested	O
in	O
a	O
logistic	O
regression	O
model	O
,	O
for	O
any	O
assessment	O
of	O
association	O
between	O
the	O
serological	O
status	O
of	O
the	O
camels	B-OG
(	O
dependent	O
variable	O
)	O
and	O
the	O
risk	O
factors	O
(	O
independent	O
variables	O
).	O

Initially	O
,	O
all	O
risk	O
factors	O
were	O
individually	O
screened	O
by	O
cross	O
-	O
tabulation	O
for	O
association	O
with	O
the	O
likelihood	O
of	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
using	O
Chi	O
-	O
squared	O
analysis	O
.	O

Non	O
-	O
collinear	O
variables	O
,	O
with	O
P	O
-	O
value	O
<	O
0	O
.	O
25	O
in	O
the	O
univariable	O
analysis	O
,	O
were	O
entered	O
into	O
the	O
multivariable	O
logistic	O
regression	O
model	O
.	O

During	O
the	O
analyses	O
the	O
clustering	O
nature	O
of	O
the	O
outcome	O
within	O
a	O
herd	O
was	O
considered	O
by	O
including	O
herd	O
as	O
a	O
clustering	O
variable	O
.	O

This	O
enabled	O
us	O
to	O
use	O
a	O
clustered	O
sandwich	O
estimator	O
i	O
.	O
e	O
.,	O
robust	O
standard	O
error	O
rather	O
than	O
the	O
standard	O
error	O
of	O
the	O
parameters	O
estimated	O
using	O
maximum	O
likelihood	O
method	O
.	O

The	O
results	O
of	O
the	O
logistic	O
regression	O
for	O
each	O
variable	O
were	O
expressed	O
as	O
P	O
-	O
value	O
and	O
odds	O
ratio	O
(	O
OR	O
)	O
with	O
95	O
%	O
confidence	O
intervals	O
to	O
measure	O
the	O
strength	O
of	O
associations	O
.	O

The	O
seroprevalence	O
results	O
of	O
DAT	O
and	O
ELISA	O
tests	O
were	O
compared	O
using	O
the	O
Chi	O
-	O
squared	O
test	O
and	O
their	O
concordance	O
was	O
determined	O
by	O
calculating	O
the	O
Kappa	O
index	O
.	O

Using	O
DAT	O
as	O
a	O
reference	O
test	O
,	O
the	O
diagnostic	O
sensitivity	O
(	O
Se	O
),	O
specificity	O
(	O
Sp	O
),	O
positive	O
predictive	O
value	O
(	O
PPV	O
)	O
and	O
negative	O
predictive	O
value	O
(	O
NPV	O
)	O
of	O
ELISA	O
were	O
calculated	O
and	O
interpreted	O
following	O
the	O
recommendations	O
of	O
Dohoo	O
et	O
al	O
.	O
[	O
35	O
].	O

A	O
student	O
t	O
-	O
test	O
was	O
employed	O
to	O
assess	O
the	O
mean	O
weight	O
difference	O
between	O
seropositive	O
and	O
seronegative	O
mice	B-OG
.	O

Differences	O
were	O
considered	O
significant	O
when	O
P	O
≤	O
0	O
.	O
05	O
.	O

Ethical	O
considerations	O

This	O
research	O
project	O
was	O
approved	O
by	O
the	O
animal	B-OG
ethical	O
committee	O
of	O
the	O
College	O
of	O
Veterinary	O
Medicine	O
and	O
Agriculture	O
,	O
Addis	O
Ababa	O
University	O
.	O

All	O
efforts	O
were	O
made	O
to	O
minimize	O
animal	B-OG
suffering	O
during	O
the	O
course	O
of	O
the	O
study	O
.	O

Informed	O
written	O
consents	O
were	O
obtained	O
from	O
all	O
camel	B-OG
owners	O
who	O
participated	O
in	O
the	O
study	O
.	O

Results	O

Animal	B-OG
level	O
seroprevalence	O

An	O
overall	O
T	B-OG
.	I-OG
gondii	I-OG
prevalence	O
of	O
49	O
.	O
62	O
%	O
(	O
220	O
/	O
455	O
)	O
by	O
DAT	O
and	O
40	O
.	O
49	O
%	O
(	O
179	O
/	O
451	O
)	O
by	O
indirect	O
ELISA	O
test	O
were	O
detected	O
.	O

Out	O
of	O
the	O
218	O
DAT	O
positive	O
sera	O
,	O
16	O
(	O
7	O
.	O
34	O
%)	O
were	O
negative	O
at	O
1	O
:	O
40	O
dilution	O
but	O
positive	O
at	O
1	O
:	O
4000	O
dilution	O
.	O

The	O
serum	O
samples	O
collected	O
from	O
the	O
abattoir	O
were	O
excluded	O
from	O
risk	O
factor	O
assessment	O
because	O
of	O
missing	O
information	O
for	O
most	O
variables	O
.	O

A	O
statistically	O
significant	O
difference	O
in	O
seroprevalence	O
was	O
observed	O
between	O
studied	O
PAs	O
with	O
the	O
highest	O
and	O
lowest	O
seroprevalence	O
recorded	O
from	O
Ilala	O
(	O
82	O
.	O
26	O
%)	O
and	O
Galcha	O
(	O
31	O
.	O
43	O
%)	O
PAs	O
,	O
respectively	O
(	O
P	O
=	O
0	O
.	O
0001	O
).	O

The	O
seroprevalence	O
was	O
also	O
significantly	O
different	O
between	O
age	O
groups	O
(	O
P	O
=	O
0	O
.	O
002	O
),	O
herd	O
sizes	O
(	O
P	O
=	O
0	O
.	O
011	O
)	O
and	O
history	O
of	O
abortion	O
(	O
P	O
=	O
0	O
.	O
003	O
).	O

However	O
,	O
there	O
was	O
no	O
statistically	O
significant	O
difference	O
in	O
seroprevalence	O
between	O
males	O
and	O
females	O
(	O
P	O
=	O
0	O
.	O
757	O
)	O
and	O
pastoral	O
and	O
agro	O
-	O
pastoral	O
production	O
systems	O
(	O
P	O
=	O
0	O
.	O
683	O
;	O
Table	O
1	O
).	O

Using	O
ELISA	O
,	O
the	O
PA	O
(	O
P	O
=	O
0	O
.	O
003	O
)	O
and	O
history	O
of	O
abortion	O
(	O
P	O
=	O
0	O
.	O
038	O
)	O
were	O
significantly	O
associated	O
with	O
seropositivity	O
(	O
see	O
Additional	O
file	O
1	O
:	O
Table	O
S1	O
).	O

Of	O
the	O
seropositive	O
samples	O
73	O
.	O
8	O
%	O
(	O
138	O
/	O
187	O
)	O
had	O
DAT	O
end	O
titer	O
of	O
≥	O
6000	O
.	O

The	O
DAT	O
end	O
titer	O
of	O
the	O
seropositive	O
camels	B-OG
(	O
n	O
=	O
187	O
)	O
is	O
shown	O
in	O
Figure	O
2	O
.	O
Table	O
1	O
T	B-OG
.	I-OG
gondii	I-OG
seroprevalence	O
in	O
camels	B-OG
of	O
the	O
Fentale	O
district	O
,	O
stratified	O
by	O
explanatory	O
variables	O
as	O
detected	O
by	O
DAT	O
Variable	O
Categories	O
No	O
.	O
tested	O
No	O
.	O
positive	O
%	O
seroprevalence	O
Chi	O
-	O
square	O
P	O
-	O
value	O
PAGalcha351131	O
.	O
4338	O
.	O
8441	O
<	O
0	O
.	O
001	O
Tuttuti2118640	O
.	O
76Saraweba381744	O
.	O
74Garafafate10550	O
.	O
00Turo291758	O
.	O
62Ilala625182	O
.	O
26Total38518748	O
.	O
34SexFemale20910047	O
.	O
850	O
.	O
09610	O
.	O
757Male1768749	O
.	O
43Age	O
≤	O
4	O
yrs1083734	O
.	O
2612	O
.	O
61900	O
.	O
002	O
4	O
-	O
8	O
yrs1859852	O
.	O
97	O
>	O
8	O
yrs925256	O
.	O
52PsPastoral30814848	O
.	O
050	O
.	O
16640	O
.	O
683Agro	O
-	O
pastoral773950	O
.	O
65HsSmall853945	O
.	O
889	O
.	O
06750	O
.	O
011	O
Medium1739856	O
.	O
65Large1275039	O
.	O
37AbortionNo1989045	O
.	O
458	O
.	O
62840	O
.	O
003	O
Yes111090	O
.	O
91StillbirthNo2079847	O
.	O
342	O
.	O
20110	O
.	O
138Yes22100	O
.	O
00NNMNo100	O
.	O
000	O
.	O
92180	O
.	O
337Yes20810048	O
.	O
08PA	O
=	O
pastoral	O
association	O
,	O
Hs	O
=	O
herd	O
size	O
,	O
Ps	O
=	O
production	O
system	O
,	O
NNM	O
=	O
neonatal	O
mortality	O
,	O
P	O
-	O
values	O
of	O
statistically	O
significant	O
variables	O
were	O
highlighted	O
in	O
bold	O
;	O
No	O
.	O
=	O
number	O
.	O
Figure	O
2	O
DAT	O
end	O
titer	O
of	O
seropositive	O
camels	B-OG
(	O
n	O
=	O
183	O
).	O

Herd	O
level	O
seroprevalence	O

Out	O
of	O
31	O
camel	B-OG
herds	O
examined	O
,	O
30	O
(	O
96	O
.	O
77	O
%)	O
(	O
95	O
%	O
CI	O
:	O
83	O
.	O
30	O
–	O
99	O
.	O
92	O
)	O
and	O
29	O
(	O
93	O
.	O
55	O
%)	O
(	O
95	O
%	O
CI	O
:	O
78	O
.	O
58	O
–	O
99	O
.	O
21	O
)	O
herds	O
were	O
seropositive	O
by	O
the	O
DAT	O
and	O
ELISA	O
test	O
,	O
respectively	O
(	O
i	O
.	O
e	O
.,	O
contain	O
at	O
least	O
one	O
seropositive	O
camel	B-OG
).	O

Using	O
DAT	O
,	O
herd	O
level	O
seroprevalence	O
of	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
was	O
not	O
significantly	O
associated	O
with	O
PAs	O
(	O
P	O
=	O
0	O
.	O
372	O
),	O
production	O
system	O
(	O
P	O
=	O
0	O
.	O
170	O
),	O
herd	O
size	O
(	O
P	O
=	O
0	O
.	O
576	O
),	O
history	O
of	O
abortion	O
(	O
P	O
=	O
0	O
.	O
549	O
)	O
and	O
presence	O
of	O
domestic	O
cats	B-OG
(	O
P	O
=	O
0	O
.	O
549	O
).	O

However	O
,	O
there	O
was	O
significant	O
association	O
between	O
herd	O
seroprevalence	O
and	O
presence	O
of	O
wild	O
felids	B-OG
(	O
P	O
=	O
0	O
.	O
038	O
;	O
Table	O
2	O
).	O

Using	O
ELISA	O
,	O
herd	O
level	O
seroprevalence	O
was	O
not	O
associated	O
with	O
the	O
studied	O
variables	O
except	O
neonatal	O
mortality	O
(	O
see	O
Additional	O
file	O
1	O
:	O
Table	O
S2	O
).	O
Table	O
2	O
Herd	O
level	O
seroprevalence	O
of	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
in	O
camels	B-OG
of	O
the	O
Fentale	O
district	O
as	O
detected	O
by	O
DAT	O
Variable	O
Categories	O
No	O
.	O
tested	O
No	O
.	O
positive	O
%	O
seroprevalence	O
Chi	O
-	O
square	O
P	O
-	O
value	O
PAGalcha441005	O
.	O
37330	O
.	O
372Tuttuti1111100Saraweba5480Garafafate22100Turo44100Ilala55100PsPastoral20201001	O
.	O
87880	O
.	O
170Agro	O
-	O
pastoral111090	O
.	O
91HsSmall151493	O
.	O
331	O
.	O
0220	O
.	O
576Medium1111100Large55100AbortionYes881000	O
.	O
35940	O
.	O
549No232195	O
.	O
65StillbirthYes331000	O
.	O
11070	O
.	O
739No282796	O
.	O
43NNMYes221000	O
.	O
07130	O
.	O
790No292896	O
.	O
55CatYes881000	O
.	O
35940	O
.	O
549No232295	O
.	O
65WfYes25251004	O
.	O
30560	O
.	O
038	O
No6583	O
.	O
33RiverYes2929100	O
--	O
PA	O
=	O
pastoral	O
association	O
,	O
Hs	O
=	O
herd	O
size	O
,	O
Ps	O
=	O
production	O
system	O
,	O
Wf	O
=	O
presence	O
of	O
wild	O
felids	B-OG
,	O
NNM	O
=	O
neonatal	O
mortality	O
,	O
No	O
.	O
=	O
number	O
.	O

Risk	O
factors	O
for	O
T	B-OG
.	I-OG
gondii	I-OG
seropositivity	O

Univariable	O
logistic	O
regression	O
analysis	O

Epidemiological	O
risk	O
factors	O
for	O
acquiring	O
T	B-OG
.	I-OG
gondii	I-OG
between	O
DAT	O
seroreactive	O
and	O
nonreactive	O
camels	B-OG
were	O
compared	O
using	O
univariable	O
logistic	O
regression	O
analysis	O
.	O

During	O
the	O
statistical	O
analysis	O
the	O
first	O
level	O
/	O
category	O
(	O
with	O
lowest	O
seroprevalence	O
)	O
of	O
each	O
independent	O
variable	O
was	O
used	O
as	O
the	O
reference	O
category	O
.	O

The	O
results	O
showed	O
that	O
sex	O
,	O
herd	O
size	O
and	O
production	O
system	O
had	O
no	O
significant	O
association	O
with	O
T	B-OG
.	I-OG
gondii	I-OG
seropositivity	O
of	O
the	O
camels	B-OG
(	O
P	O
>	O
0	O
.	O
05	O
)	O
while	O
study	O
area	O
,	O
age	O
,	O
history	O
of	O
abortion	O
,	O
presence	O
of	O
domestic	O
cats	B-OG
and	O
presence	O
of	O
wild	O
felids	B-OG
were	O
found	O
to	O
be	O
significantly	O
associated	O
with	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
(	O
P	O
<	O
0	O
.	O
05	O
)	O
(	O
Table	O
3	O
).	O
Table	O
3	O
Animal	B-OG
level	O
Logistic	O
regression	O
analysis	O
of	O
predictors	O
of	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
in	O
Camels	B-OG
as	O
detected	O
by	O
DAT	O
Variable	O
Category	O
No	O
.	O
of	O
positive	O
/	O
tested	O
(%)	O
Univariable	O
Multivariable	O
OR	O
(	O
95	O
%	O
CI	O
)	O
P	O
OR	O
(	O
95	O
%	O
CI	O
)	O
P	O
PAGalcha11	O
/	O
35	O
(	O
31	O
.	O
43	O
)	O
11	O
-	O
Tuttuti86	O
/	O
211	O
(	O
40	O
.	O
75	O
)	O
1	O
.	O
5	O
(	O
0	O
.	O
58	O
-	O
3	O
.	O
88	O
)	O
0	O
.	O
4021	O
.	O
55	O
(	O
0	O
.	O
60	O
-	O
3	O
.	O
99	O
)	O
0	O
.	O
367Saraweba17	O
/	O
38	O
(	O
44	O
.	O
74	O
)	O
1	O
.	O
77	O
(	O
0	O
.	O
45	O
-	O
6	O
.	O
97	O
)	O
0	O
.	O
4171	O
.	O
5	O
(	O
0	O
.	O
63	O
-	O
3	O
.	O
58	O
)	O
0	O
.	O
357Garafafate5	O
/	O
10	O
(	O
50	O
)	O
2	O
.	O
18	O
(	O
0	O
.	O
87	O
-	O
5	O
.	O
45	O
)	O
0	O
.	O
0950	O
.	O
6	O
3	O
(	O
0	O
.	O
17	O
-	O
2	O
.	O
33	O
)	O
0	O
.	O
487Turo17	O
/	O
29	O
(	O
58	O
.	O
62	O
)	O
3	O
.	O
1	O
(.	O
77	O
-	O
12	O
.	O
34	O
)	O
0	O
.	O
1101	O
.	O
06	O
(.	O
23	O
-	O
4	O
.	O
94	O
)	O
0	O
.	O
940Ilala51	O
/	O
62	O
(	O
82	O
.	O
26	O
)	O
10	O
.	O
11	O
(	O
4	O
.	O
3	O
-	O
24	O
.	O
21	O
)<	O
0	O
.	O
001	O
10	O
.	O
8	O
(	O
4	O
.	O
83	O
-	O
24	O
.	O
17	O
)<	O
0	O
.	O
001	O
SexFemale100	O
/	O
209	O
(	O
47	O
.	O
85	O
)	O
1Male87	O
/	O
176	O
(	O
49	O
.	O
43	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
70	O
-	O
1	O
.	O
62	O
)	O
0	O
.	O
767Age	O
≤	O
4	O
yrs37	O
/	O
108	O
(	O
34	O
.	O
26	O
)	O
11	O
-	O
4	O
-	O
8	O
yrs98	O
/	O
185	O
(	O
52	O
.	O
97	O
)	O
2	O
.	O
16	O
(	O
1	O
.	O
28	O
-	O
3	O
.	O
64	O
)	O
0	O
.	O
004	O
1	O
.	O
73	O
(	O
0	O
.	O
99	O
-	O
3	O
.	O
02	O
)	O
0	O
.	O
053	O
>	O
8	O
yrs52	O
/	O
92	O
(	O
56	O
.	O
52	O
)	O
2	O
.	O
49	O
(	O
1	O
.	O
34	O
-	O
4	O
.	O
65	O
)	O
0	O
.	O
004	O
1	O
.	O
88	O
(	O
1	O
.	O
05	O
-	O
3	O
.	O
37	O
)	O
0	O
.	O
033	O
Ps1	O
Pastoral148	O
/	O
308	O
(	O
48	O
.	O
05	O
)	O
1Agro	O
-	O
pastoral39	O
/	O
77	O
(	O
50	O
.	O
65	O
)	O
1	O
.	O
12	O
(	O
0	O
.	O
46	O
-	O
2	O
.	O
64	O
)	O
0	O
.	O
814CatNo173	O
/	O
305	O
(	O
43	O
.	O
28	O
)	O
11	O
-	O
Yes55	O
/	O
80	O
(	O
68	O
.	O
75	O
)	O
2	O
.	O
88	O
(	O
1	O
.	O
28	O
-	O
6	O
.	O
47	O
)	O
0	O
.	O
010	O
4	O
.	O
16	O
(	O
1	O
.	O
49	O
-	O
11	O
.	O
61	O
)	O
0	O
.	O
006	O
Wf2	O
No18	O
/	O
80	O
(	O
22	O
.	O
5	O
)	O
11	O
-	O
Yes169	O
/	O
305	O
(	O
55	O
.	O
41	O
)	O
4	O
.	O
28	O
(	O
2	O
.	O
40	O
-	O
7	O
.	O
63	O
)	O
<	O
0	O
.	O
001	O
2	O
.	O
04	O
(	O
0	O
.	O
86	O
-	O
4	O
.	O
83	O
)	O
0	O
.	O
104AbortionNo90	O
/	O
198	O
(	O
45	O
.	O
45	O
)	O
11	O
-	O
Yes10	O
/	O
11	O
(	O
90	O
.	O
91	O
)	O
12	O
.	O
0	O
(	O
1	O
.	O
25	O
-	O
114	O
.	O
96	O
)	O
0	O
.	O
031	O
9	O
.	O
23	O
(	O
0	O
.	O
8	O
-	O
107	O
.	O
05	O
)	O
0	O
.	O
075Hs3	O
Small39	O
/	O
85	O
(	O
45	O
.	O
88	O
)	O
1Medium98	O
/	O
173	O
(	O
56	O
.	O
65	O
)	O
1	O
.	O
54	O
(	O
0	O
.	O
59	O
-	O
4	O
.	O
01	O
)	O
0	O
.	O
376Large50	O
/	O
127	O
(	O
39	O
.	O
37	O
)	O
0	O
.	O
76	O
(	O
0	O
.	O
26	O
-	O
2	O
.	O
29	O
)	O
0	O
.	O
633	O
1Production	O
system	O
,	O
2Wild	O
felids	B-OG
,	O
3Herd	O
size	O
.	O

Multivariable	O
logistic	O
regression	O
analysis	O

Stillbirth	O
and	O
neonatal	O
mortality	O
were	O
not	O
included	O
in	O
the	O
multivariable	O
model	O
due	O
to	O
collinearity	O
with	O
abortion	O
.	O

Five	O
variables	O
(	O
study	O
area	O
[	O
PAs	O
],	O
age	O
,	O
abortion	O
,	O
exposure	O
to	O
domestic	O
and	O
wild	O
cats	B-OG
)	O
that	O
presented	O
P	O
-	O
value	O
<	O
0	O
.	O
25	O
in	O
the	O
univariable	O
analysis	O
,	O
were	O
subjected	O
to	O
the	O
multivariable	O
regression	O
model	O
.	O

The	O
analysis	O
showed	O
a	O
significant	O
association	O
between	O
T	B-OG
.	I-OG
gondii	I-OG
seropositivity	O
and	O
study	O
area	O
(	O
PAs	O
)	O
(	O
P	O
=	O
0	O
.	O
0001	O
),	O
age	O
(	O
P	O
=	O
0	O
.	O
033	O
)	O
and	O
the	O
presence	O
of	O
domestic	O
cats	B-OG
(	O
P	O
=	O
0	O
.	O
006	O
;	O
Table	O
3	O
).	O

The	O
results	O
of	O
the	O
logistic	O
regression	O
analysis	O
based	O
on	O
the	O
results	O
of	O
the	O
ELISA	O
were	O
presented	O
as	O
Additional	O
file	O
1	O
:	O
Table	O
S3	O
).	O

Camel	B-OG
owners	O
food	O
habit	O
and	O
awareness	O
about	O
toxoplasmosis	B-DS

All	O
(	O
100	O
%)	O
camel	B-OG
owners	O
who	O
responded	O
to	O
the	O
questionnaire	O
survey	O
were	O
uneducated	O
pastoralists	O
,	O
had	O
no	O
awareness	O
about	O
T	B-OG
.	I-OG
gondii	I-OG
,	O
toxoplasmosis	B-DS
and	O
its	O
transmission	O
to	O
humans	B-OG
through	O
raw	O
meat	O
and	O
raw	O
milk	O
consumption	O
.	O

Camel	B-OG
meat	O
consumption	O
habit	O
showed	O
that	O
67	O
.	O
7	O
%	O
consume	O
cooked	O
meat	O
and	O
the	O
rest	O
(	O
32	O
.	O
3	O
%)	O
consume	O
either	O
cooked	O
or	O
uncooked	O
meat	O
.	O

All	O
respondents	O
(	O
100	O
%)	O
consume	O
raw	O
camel	B-OG
milk	O
,	O
handle	O
aborted	O
fetus	O
with	O
bare	O
hands	O
(	O
no	O
protection	O
)	O
and	O
don	O
’	O
t	O
wash	O
their	O
hands	O
after	O
handling	O
aborted	O
fetus	O
.	O

Furthermore	O
,	O
none	O
of	O
the	O
camel	B-OG
owners	O
bury	O
or	O
burn	O
aborted	O
materials	O
;	O
rather	O
they	O
simply	O
dispose	O
of	O
by	O
throwing	O
it	O
in	O
the	O
field	O
.	O

Comparison	O
of	O
seroprevalence	O
results	O
of	O
DAT	O
and	O
ELISA	O
tests	O

Overall	O
,	O
the	O
451	O
serum	O
samples	O
were	O
tested	O
by	O
both	O
DAT	O
and	O
ELISA	O
kits	O
for	O
comparison	O
.	O

A	O
total	O
agreement	O
between	O
the	O
two	O
tests	O
was	O
obtained	O
on	O
132	O
positive	O
samples	O
(	O
29	O
.	O
27	O
%)	O
and	O
186	O
(	O
41	O
.	O
24	O
%)	O
negative	O
samples	O
.	O

But	O
86	O
sera	O
were	O
positive	O
only	O
by	O
DAT	O
test	O
and	O
47	O
sera	O
were	O
positive	O
only	O
by	O
ELISA	O
test	O
.	O

Comparison	O
of	O
the	O
two	O
test	O
results	O
indicated	O
that	O
seropositivity	O
differed	O
significantly	O
between	O
the	O
two	O
kits	O
(	O
χ2	O
=	O
76	O
.	O
714	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

However	O
,	O
Kappa	O
analysis	O
demonstrated	O
that	O
the	O
two	O
tests	O
had	O
a	O
moderate	O
agreement	O
in	O
detecting	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
in	O
camels	B-OG
(	O
70	O
.	O
51	O
%	O
agreement	O
,	O
Kappa	O
=	O
0	O
.	O
41	O
;	O
P	O
<	O
0	O
.	O
0001	O
).	O

By	O
considering	O
DAT	O
as	O
a	O
reference	O
test	O
,	O
the	O
sensitivity	O
,	O
specificity	O
,	O
and	O
positive	O
and	O
negative	O
predictive	O
values	O
of	O
ELISA	O
was	O
calculated	O
as	O
60	O
.	O
55	O
%,	O
79	O
.	O
83	O
%,	O
and	O
73	O
.	O
74	O
%	O
and	O
68	O
.	O
38	O
%,	O
respectively	O
.	O

Bioassay	O

Of	O
the	O
70	O
camel	B-OG
sera	O
from	O
the	O
abattoir	O
,	O
33	O
(	O
47	O
.	O
1	O
%)	O
(	O
95	O
%	O
CI	O
:	O
35	O
.	O
09	O
-	O
59	O
.	O
45	O
)	O
and	O
29	O
(	O
41	O
.	O
43	O
%)	O
(	O
95	O
%	O
CI	O
:	O
29	O
.	O
77	O
-	O
53	O
.	O
83	O
)	O
were	O
IgG	B-GP
seropositive	O
using	O
DAT	O
and	O
ELISA	O
,	O
respectively	O
.	O

Viable	O
T	B-OG
.	I-OG
gondii	I-OG
cysts	B-DS
were	O
isolated	O
from	O
5	O
of	O
31	O
DAT	O
seropositive	O
bioassayed	O
camels	B-OG
(	O
16	O
.	O
13	O
%).	O

Out	O
of	O
the	O
31	O
DAT	O
positive	O
sera	O
,	O
22	O
were	O
positive	O
for	O
ELISA	O
and	O
one	O
ELISA	O
negative	O
camel	B-OG
sample	O
gave	O
a	O
cyst	B-DS
positive	O
result	O
.	O

For	O
two	O
seropositive	O
camel	B-OG
samples	O
,	O
isolation	O
of	O
the	O
parasite	O
was	O
not	O
possible	O
because	O
of	O
the	O
death	O
of	O
all	O
of	O
the	O
inoculated	O
mice	B-OG
within	O
a	O
day	O
of	O
inoculation	O
.	O

On	O
day	O
60	O
post	O
-	O
inoculation	O
,	O
out	O
of	O
108	O
mice	B-OG
that	O
survived	O
,	O
22	O
(	O
20	O
.	O
4	O
%)	O
were	O
seropositive	O
for	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
(	O
i	O
.	O
e	O
.,	O
out	O
of	O
31	O
camel	B-OG
samples	O
,	O
10	O
(	O
32	O
.	O
3	O
%)	O
gave	O
a	O
seropositive	O
result	O
on	O
mice	B-OG
).	O

Viable	O
cysts	B-DS
were	O
isolated	O
in	O
mice	B-OG
from	O
5	O
tissue	O
samples	O
from	O
the	O
camels	B-OG
(	O
on	O
5	O
seropositive	O
and	O
1	O
seronegative	O
mice	B-OG
)	O
(	O
Table	O
4	O
).	O

It	O
was	O
not	O
possible	O
to	O
detect	O
cysts	B-DS
from	O
17	O
of	O
the	O
seropositive	O
mice	B-OG
.	O

Eleven	O
out	O
of	O
108	O
survived	O
mice	B-OG
showed	O
loss	O
of	O
weight	O
(	O
10	O
.	O
2	O
%),	O
of	O
which	O
9	O
and	O
2	O
mice	B-OG
were	O
seropositive	O
and	O
seronegative	O
,	O
respectively	O
,	O
i	O
.	O
e	O
.,	O
40	O
.	O
9	O
%	O
(	O
9	O
/	O
22	O
)	O
of	O
seropositive	O
and	O
2	O
.	O
3	O
%	O
(	O
2	O
/	O
86	O
)	O
of	O
seronegative	O
mice	B-OG
showed	O
loss	O
of	O
weight	O
.	O

The	O
mean	O
weight	O
change	O
between	O
seropositive	O
(	O
infected	O
,	O
mean	O
=	O
0	O
.	O
25	O
g	O
±	O
6	O
.	O
58	O
)	O
and	O
seronegative	O
(	O
non	O
-	O
infected	O
,	O
mean	O
=	O
5	O
.	O
55	O
g	O
±	O
3	O
.	O
41	O
)	O
mice	B-OG
was	O
significantly	O
different	O
(	O
P	O
<	O
0	O
.	O
0001	O
).	O

The	O
mean	O
cyst	B-DS
count	O
per	O
mouse	B-OG
brain	O
was	O
46	O
.	O
5	O
(	O
range	O
:	O
28	O
–	O
88	O
).	O

One	O
mouse	B-OG
that	O
showed	O
neurological	O
signs	O
(	O
hind	O
quarter	O
paralysis	O
,	O
torticollis	O
)	O
and	O
tachypnoea	O
on	O
day	O
20	O
post	O
-	O
inoculation	O
became	O
cyst	B-DS
negative	O
but	O
seropositive	O
.	O
Table	O
4	O
Isolation	O
of	O
T	B-OG
.	I-OG
gondii	I-OG
from	O
naturally	O
infected	O
seropositive	O
camels	B-OG
of	O
East	O
Shewa	O
Zones	O
,	O
Central	O
Ethiopia	O
Camel	B-OG
no	O
.	O
Sex	O
Age	O
group	O
DAT	O
screening	O
Mice	B-OG
with	O
cyst	B-DS
/	O
examined	O
(	O
n	O
)	O
Mice	B-OG
seropositive	O
/	O
examined	O
(	O
n	O
)	O
Days	O
of	O
mice	B-OG
death	O
PI	O
(	O
no	O
.	O
of	O
mice	B-OG
dead	O
)	O
H1M	O
≥	O
8	O
Yrs1	O
/	O
400	O
/	O
50	O
/	O
5H2M	O
≥	O
8	O
Yrs1	O
/	O
40	O
&	O
1	O
/	O
40000	O
/	O
50	O
/	O
5H4M4	O
-	O
8	O
Yrs1	O
/	O
40	O
&	O
1	O
/	O
40001	O
/	O
50	O
/	O
5H6M	O
≥	O
8	O
Yrs1	O
/	O
400	O
/	O
30	O
/	O
31	O
(	O
1	O
),	O
2	O
(	O
1	O
)	O
H9M	O
≥	O
8	O
Yrs1	O
/	O
40	O
&	O
1	O
/	O
40002	O
/	O
55	O
/	O
5H11M4	O
-	O
8	O
Yrs1	O
/	O
40	O
&	O
1	O
/	O
40000	O
/	O
40	O
/	O
41	O
(	O
3	O
)	O
H15F	O
≥	O
8	O
Yrs1	O
/	O
40	O
&	O
1	O
/	O
40000	O
/	O
30	O
/	O
32	O
(	O
3	O
)	O
H19M	O
≥	O
8	O
Yrs1	O
/	O
401	O
/	O
51	O
/	O
5H20M	O
≥	O
8	O
Yrs1	O
/	O
40	O
&	O
1	O
/	O
40001	O
/	O
55	O
/	O
5H23M	O
≤	O
4	O
Yrs1	O
/	O
40000	O
/	O
31	O
/	O
32	O
(	O
2	O
)	O
H25M	O
≥	O
8	O
Yrs1	O
/	O
40	O
&	O
1	O
/	O
40001	O
/	O
33	O
/	O
32	O
(	O
2	O
)	O
H28F	O
≤	O
4	O
Yrs1	O
/	O
40	O
&	O
1	O
/	O
40000	O
/	O
43	O
/	O
41	O
(	O
2	O
)	O
H30F	O
≥	O
8	O
Yrs1	O
/	O
40	O
&	O
1	O
/	O
40000	O
/	O
11	O
/	O
14	O
(	O
1	O
)	O
H33	O
,	O
H43F	O
≥	O
8	O
Yrs1	O
/	O
40	O
&	O
1	O
/	O
40000	O
/	O
50	O
/	O
5H39M	O
≥	O
8	O
Yrs1	O
/	O
40000	O
/	O
50	O
/	O
5H44F4	O
-	O
8	O
Yrs1	O
/	O
40	O
&	O
1	O
/	O
40000	O
/	O
51	O
/	O
5H45F4	O
-	O
8	O
Yrs1	O
/	O
40	O
&	O
1	O
/	O
40000	O
/	O
41	O
/	O
41	O
(	O
1	O
)	O
H55F	O
≤	O
4	O
Yrs1	O
/	O
40	O
&	O
1	O
/	O
40000	O
/	O
30	O
/	O
31	O
(	O
2	O
)	O
H56	O
,	O
H60	O
,	O
H65F4	O
-	O
8	O
Yrs1	O
/	O
40	O
&	O
1	O
/	O
40000	O
/	O
50	O
/	O
5H63F4	O
-	O
8	O
Yrs1	O
/	O
40000	O
/	O
50	O
/	O
5H59M4	O
-	O
8	O
Yrs1	O
/	O
40000	O
/	O
40	O
/	O
42	O
(	O
2	O
)	O
H61	O
,	O
H64F4	O
-	O
8	O
Yrs1	O
/	O
40000	O
/	O
40	O
/	O
42	O
(	O
1	O
),	O
2	O
(	O
1	O
)	O
H62F4	O
-	O
8	O
Yrs1	O
/	O
40	O
&	O
1	O
/	O
40000	O
/	O
40	O
/	O
41	O
(	O
1	O
)	O
H66F	O
≤	O
4	O
Yrs1	O
/	O
40000	O
/	O
51	O
/	O
5H67F	O
≥	O
8	O
Yrs1	O
/	O
40	O
&	O
1	O
/	O
40000	O
/	O
40	O
/	O
42	O
(	O
1	O
)	O
H68M4	O
-	O
8	O
Yrs1	O
/	O
40	O
&	O
1	O
/	O
40000	O
/	O
30	O
/	O
31	O
(	O
2	O
),	O
1	O
(	O
3	O
)	O
H69F	O
≥	O
8	O
Yrs1	O
/	O
40	O
&	O
1	O
/	O
40000	O
/	O
10	O
/	O
14	O
(	O
1	O
)	O

Discussion	O

Overall	O
seroprevalence	O

We	O
report	O
for	O
the	O
first	O
time	O
evidence	O
for	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
and	O
its	O
seroprevalence	O
,	O
risk	O
factors	O
and	O
bioassay	O
results	O
in	O
Ethiopian	O
camels	B-OG
.	O

An	O
estimated	O
overall	O
seroprevalence	O
of	O
49	O
.	O
623	O
%	O
by	O
DAT	O
and	O
40	O
.	O
49	O
%	O
by	O
ELISA	O
tests	O
were	O
detected	O
.	O

Seventy	O
-	O
four	O
percent	O
of	O
seropositive	O
camels	B-OG
(	O
from	O
field	O
samples	O
)	O
had	O
DAT	O
end	O
titer	O
of	O
≥	O
6000	O
.	O

This	O
might	O
indicate	O
actively	O
circulating	O
,	O
recently	O
acquired	O
or	O
recrudescence	O
of	O
previously	O
acquired	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
in	O
camels	B-OG
of	O
the	O
study	O
area	O
due	O
to	O
climatic	O
stress	O
,	O
malnutrition	B-DS
and	O
prevalent	O
diseases	O
like	O
trypanosomosis	B-DS
[	O
36	O
]	O
which	O
reduce	O
the	O
animals	B-OG
’	O
resistance	O
[	O
37	O
].	O

Moreover	O
,	O
the	O
seropositive	O
sera	O
that	O
became	O
negative	O
at	O
1	O
:	O
40	O
but	O
positive	O
at	O
1	O
:	O
4000	O
dilutions	O
(	O
7	O
.	O
34	O
%,	O
16	O
/	O
218	O
)	O
indicate	O
prozone	O
phenomenon	O
.	O

Presence	O
of	O
viable	O
T	B-OG
.	I-OG
gondii	I-OG
cysts	B-DS
in	O
16	O
.	O
13	O
%	O
(	O
5	O
/	O
31	O
)	O
of	O
camels	B-OG
slaughtered	O
for	O
human	B-OG
consumption	O
is	O
definitive	O
diagnosis	O
of	O
natural	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
and	O
suggests	O
the	O
potential	O
transmission	O
of	O
toxoplasmosis	B-DS
to	O
humans	B-OG
through	O
consumption	O
of	O
raw	O
or	O
undercooked	O
camel	B-OG
meat	O
or	O
offal	O
such	O
as	O
the	O
liver	O
which	O
is	O
commonly	O
consumed	O
by	O
pastoralists	O
.	O

Considering	O
the	O
lower	O
human	B-OG
population	O
density	O
(	O
hence	O
possibly	O
lower	O
domestic	O
cat	B-OG
density	O
),	O
the	O
arid	O
and	O
semi	O
-	O
arid	O
climate	O
of	O
the	O
Fentale	O
district	O
,	O
which	O
is	O
hostile	O
for	O
the	O
survival	O
of	O
oocysts	O
in	O
the	O
environment	O
,	O
and	O
the	O
browsing	O
habit	O
of	O
camel	B-OG
feeding	O
(	O
hence	O
lower	O
risk	O
of	O
acquiring	O
T	B-OG
.	I-OG
gondii	I-OG
oocysts	O
from	O
the	O
ground	O
),	O
the	O
high	O
seroprevalence	O
found	O
in	O
the	O
present	O
study	O
was	O
not	O
to	O
our	O
expectation	O
.	O

Recently	O
,	O
a	O
relatively	O
lower	O
seroprevalence	O
of	O
T	B-OG
.	I-OG
gondii	I-OG
in	O
goats	B-OG
(	O
15	O
.	O
37	O
%)	O
[	O
25	O
]	O
and	O
in	O
sheep	B-OG
(	O
13	O
.	O
36	O
%)	O
[	O
23	O
]	O
was	O
reported	O
from	O
the	O
same	O
district	O
.	O

However	O
,	O
the	O
high	O
seroprevalence	O
in	O
camels	B-OG
of	O
the	O
current	O
study	O
in	O
our	O
opinion	O
might	O
be	O
a	O
function	O
of	O
cumulative	O
effect	O
of	O
the	O
age	O
of	O
camels	B-OG
[	O
38	O
]	O
related	O
to	O
absence	O
of	O
regular	O
culling	O
programs	O
.	O

Moreover	O
,	O
the	O
migration	O
of	O
camels	B-OG
to	O
midland	O
areas	O
in	O
search	O
of	O
feed	O
,	O
the	O
poor	O
veterinary	O
service	O
,	O
inadequate	O
attention	O
by	O
government	O
,	O
local	O
change	O
in	O
landownership	O
and	O
increased	O
farming	O
[	O
5	O
]	O
-	O
which	O
necessitate	O
cat	B-OG
keeping	O
to	O
control	O
rodents	B-OG
,	O
might	O
have	O
additionally	O
contributed	O
to	O
the	O
high	O
prevalence	O
.	O

The	O
present	O
seroprevalence	O
(	O
48	O
.	O
34	O
%)	O
is	O
in	O
close	O
agreement	O
with	O
the	O
51	O
.	O
3	O
%	O
and	O
46	O
%	O
-	O
54	O
.	O
2	O
%	O
seroprevalence	O
reported	O
from	O
Sudan	O
[	O
39	O
]	O
and	O
Egypt	O
[	O
40	O
,	O
41	O
],	O
respectively	O
.	O

As	O
compared	O
to	O
the	O
present	O
finding	O
,	O
much	O
higher	O
seroprevalence	O
has	O
been	O
reported	O
from	O
Turkey	O
(	O
90	O
.	O
9	O
%)	O
and	O
Sudan	O
(	O
67	O
%)	O
by	O
Utuk	O
et	O
al	O
.	O
[	O
11	O
]	O
and	O
Elamin	O
et	O
al	O
.	O
[	O
8	O
],	O
respectively	O
.	O

Lower	O
seroprevalence	O
was	O
recorded	O
earlier	O
from	O
Iran	O
3	O
.	O
12	O
%	O
[	O
10	O
],	O
Saudi	O
Arabia	O
6	O
.	O
5	O
%	O
[	O
42	O
],	O
16	O
%	O
[	O
43	O
],	O
13	O
.	O
1	O
%	O
[	O
44	O
],	O
Sudan	O
(	O
20	O
%)	O
[	O
45	O
],	O
United	O
Arab	O
Emirates	O
(	O
22	O
.	O
4	O
%)	O
[	O
46	O
]	O
and	O
Egypt	O
(	O
17	O
.	O
4	O
-	O
31	O
.	O
4	O
%)	O
[	O
9	O
,	O
47	O
,	O
48	O
].	O

The	O
variation	O
in	O
seroprevalence	O
between	O
the	O
present	O
study	O
and	O
aforementioned	O
African	O
and	O
Arabian	O
countries	O
might	O
be	O
due	O
to	O
the	O
difference	O
in	O
density	O
of	O
cats	B-OG
and	O
wild	O
felids	B-OG
,	O
climatic	O
conditions	O
[	O
13	O
],	O
farming	O
and	O
management	O
practices	O
[	O
49	O
],	O
sample	O
size	O
[	O
45	O
],	O
cut	O
-	O
off	O
values	O
and	O
sensitivity	O
difference	O
in	O
the	O
serological	O
tests	O
employed	O
[	O
13	O
,	O
42	O
].	O

Risk	O
factors	O

Assessment	O
of	O
the	O
association	O
of	O
T	B-OG
.	I-OG
gondii	I-OG
seroprevalence	O
with	O
potential	O
risk	O
factors	O
was	O
made	O
with	O
the	O
aim	O
of	O
identifying	O
factors	O
relevant	O
for	O
prevention	O
of	O
the	O
disease	O
.	O

Accordingly	O
,	O
using	O
the	O
results	O
of	O
DAT	O
,	O
a	O
multivariable	O
logistic	O
regression	O
model	O
revealed	O
that	O
study	O
PA	O
(	O
P	O
=	O
0	O
.	O
001	O
),	O
exposure	O
to	O
domestic	O
cats	B-OG
(	O
P	O
=	O
0	O
.	O
006	O
)	O
and	O
age	O
of	O
the	O
camels	B-OG
(	O
P	O
=	O
0	O
.	O
033	O
)	O
were	O
found	O
to	O
be	O
independent	O
predictors	O
of	O
T	B-OG
.	I-OG
gondii	I-OG
seropositivity	O
.	O

On	O
the	O
other	O
hand	O
,	O
only	O
study	O
PA	O
(	O
P	O
=	O
0	O
.	O
006	O
)	O
and	O
exposure	O
to	O
domestic	O
cats	B-OG
(	O
P	O
=	O
0	O
.	O
011	O
)	O
were	O
found	O
to	O
be	O
independent	O
predictors	O
of	O
T	B-OG
.	I-OG
gondii	I-OG
seropositivity	O
using	O
results	O
of	O
ELISA	O
(	O
see	O
Additional	O
file	O
1	O
).	O

This	O
suggests	O
that	O
DAT	O
is	O
a	O
more	O
preferred	O
test	O
for	O
assessing	O
the	O
risk	O
factors	O
in	O
camels	B-OG
than	O
ELISA	O
.	O

Camels	B-OG
from	O
Ilala	O
PA	O
(	O
82	O
.	O
26	O
%)	O
are	O
10	O
.	O
8	O
times	O
more	O
likely	O
to	O
be	O
seropositive	O
than	O
camels	B-OG
of	O
Galcha	O
PA	O
(	O
31	O
.	O
43	O
%)	O
[	O
P	O
<	O
0	O
.	O
001	O
].	O

The	O
observed	O
difference	O
in	O
seroprevalence	O
across	O
PAs	O
could	O
be	O
due	O
to	O
differences	O
in	O
the	O
age	O
of	O
camels	B-OG
sampled	O
[	O
50	O
],	O
the	O
sample	O
size	O
[	O
44	O
],	O
the	O
degree	O
of	O
environmental	O
contamination	O
[	O
13	O
]	O
and	O
the	O
frequency	O
of	O
exposure	O
to	O
risk	O
factors	O
[	O
51	O
].	O

The	O
seroprevalence	O
of	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
was	O
higher	O
in	O
camels	B-OG
older	O
than	O
8	O
years	O
(	O
OR	O
=	O
2	O
.	O
49	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
34	O
,	O
4	O
.	O
65	O
)	O
as	O
compared	O
to	O
camels	B-OG
≤	O
4	O
years	O
old	O
.	O

Thus	O
,	O
the	O
probability	O
of	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
in	O
camels	B-OG
increases	O
as	O
the	O
age	O
of	O
the	O
animal	B-OG
increases	O
suggesting	O
postnatal	B-DS
infection	I-DS
.	O

The	O
high	O
seroprevalence	O
in	O
older	O
camels	B-OG
than	O
young	O
camels	B-OG
might	O
be	O
due	O
to	O
the	O
higher	O
likelihood	O
of	O
exposure	O
of	O
older	O
camels	B-OG
to	O
any	O
one	O
of	O
the	O
risk	O
factors	O
to	O
acquire	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
[	O
52	O
].	O

This	O
finding	O
is	O
in	O
harmony	O
with	O
the	O
studies	O
conducted	O
in	O
Saudi	O
Arabia	O
[	O
8	O
,	O
43	O
]	O
who	O
reported	O
a	O
higher	O
seroprevalence	O
in	O
adult	O
than	O
young	O
camels	B-OG
.	O

The	O
univariable	O
logistic	O
regression	O
showed	O
that	O
the	O
odds	O
of	O
being	O
infected	O
by	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
was	O
higher	O
in	O
aborted	O
camels	B-OG
than	O
non	O
-	O
aborted	O
camels	B-OG
(	O
OR	O
=	O
12	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
25	O
,	O
114	O
.	O
95	O
;	O
P	O
=	O
0	O
.	O
031	O
)	O
and	O
in	O
areas	O
where	O
the	O
presence	O
of	O
wild	O
felids	B-OG
was	O
reported	O
(	O
OR	O
=	O
4	O
.	O
28	O
,	O
95	O
%	O
CI	O
:	O
2	O
.	O
40	O
,	O
7	O
.	O
63	O
;	O
P	O
<	O
0	O
.	O
001	O
)	O
than	O
in	O
their	O
absence	O
.	O

However	O
,	O
these	O
variables	O
were	O
not	O
independent	O
predictors	O
of	O
seropositivity	O
in	O
the	O
final	O
logistic	O
regression	O
model	O
(	O
P	O
>	O
0	O
.	O
05	O
).	O

The	O
high	O
seroprevalence	O
in	O
aborted	O
camels	B-OG
is	O
consistent	O
with	O
biological	O
features	O
of	O
T	B-OG
.	I-OG
gondii	I-OG
in	O
sheep	B-OG
,	O
goats	B-OG
and	O
pigs	B-OG
.	O
T	B-OG
.	I-OG
gondii	I-OG
has	O
been	O
reported	O
as	O
an	O
important	O
cause	O
of	O
abortion	O
in	O
Bacterian	B-OG
camels	I-OG
[	O
53	O
]	O
and	O
in	O
zoo	O
camels	B-OG
in	O
USA	O
[	O
54	O
].	O

There	O
was	O
no	O
statistically	O
significant	O
sex	O
-	O
linked	O
difference	O
in	O
seroprevalence	O
between	O
male	O
(	O
49	O
.	O
43	O
%;	O
95	O
%	O
CI	O
:	O
42	O
.	O
0	O
,	O
56	O
.	O
86	O
)	O
and	O
female	O
(	O
47	O
.	O
85	O
%;	O
95	O
%	O
CI	O
:	O
41	O
.	O
0	O
,	O
54	O
.	O
65	O
)	O
camels	B-OG
.	O

This	O
is	O
consistent	O
with	O
studies	O
in	O
dromedaries	B-OG
of	O
Sudan	O
[	O
8	O
],	O
Saudi	O
Arabia	O
[	O
43	O
]	O
and	O
bactrian	B-OG
camels	I-OG
of	O
China	O
[	O
55	O
].	O

Bioassay	O

As	O
far	O
as	O
the	O
bioassay	O
result	O
is	O
concerned	O
,	O
tissue	O
cysts	B-DS
were	O
isolated	O
from	O
16	O
.	O
13	O
%	O
(	O
5	O
∕	O
31	O
)	O
of	O
DAT	O
positive	O
camels	B-OG
.	O

Bradyzoite	O
tissue	O
cysts	B-DS
were	O
detected	O
by	O
microscopy	O
in	O
22	O
.	O
73	O
%	O
(	O
5	O
/	O
22	O
)	O
of	O
DAT	O
positive	O
mice	B-OG
.	O

This	O
lower	O
rate	O
of	O
detection	O
of	O
cyst	B-DS
by	O
microscopy	O
might	O
be	O
due	O
to	O
the	O
low	O
number	O
of	O
cysts	B-DS
in	O
camel	B-OG
tissue	O
and	O
the	O
low	O
sensitivity	O
of	O
microscopy	O
[	O
13	O
].	O

Cyst	B-DS
count	O
has	O
also	O
been	O
reported	O
to	O
vary	O
depending	O
on	O
the	O
virulence	O
of	O
T	B-OG
.	I-OG
gondii	I-OG
strain	O
and	O
number	O
of	O
passages	O
in	O
the	O
mice	B-OG
[	O
56	O
].	O

Previously	O
,	O
viable	O
tissue	O
cysts	B-DS
have	O
been	O
isolated	O
in	O
cats	B-OG
from	O
naturally	O
infected	O
camels	B-OG
in	O
Saudi	O
Arabia	O
[	O
16	O
].	O

It	O
has	O
also	O
been	O
reported	O
that	O
the	O
success	O
of	O
isolation	O
of	O
T	B-OG
.	I-OG
gondii	I-OG
cysts	B-DS
as	O
well	O
as	O
the	O
number	O
of	O
tissue	O
cysts	B-DS
produced	O
vary	O
considerably	O
with	O
the	O
intermediate	O
hosts	O
,	O
being	O
higher	O
in	O
sheep	B-OG
,	O
goats	B-OG
and	O
pigs	B-OG
[	O
49	O
,	O
57	O
].	O

The	O
number	O
of	O
isolated	O
tissue	O
cysts	B-DS
ranged	O
from	O
25	O
to	O
88	O
per	O
brain	O
of	O
mice	B-OG
,	O
which	O
is	O
low	O
compared	O
to	O
the	O
number	O
of	O
cysts	B-DS
/	O
mouse	B-OG
brain	O
isolated	O
from	O
sheep	B-OG
and	O
goats	B-OG
of	O
the	O
same	O
district	O
(	O
Gebremedhin	O
et	O
al	O
.,	O
unpublished	O
).	O

More	O
sensitive	O
methods	O
like	O
PCR	O
might	O
detect	O
the	O
DNA	O
of	O
tissue	O
cysts	B-DS
in	O
the	O
brain	O
of	O
seropositive	O
mice	B-OG
presently	O
reported	O
perhaps	O
as	O
false	O
negative	O
due	O
to	O
the	O
small	O
volume	O
of	O
brain	O
homogenate	O
examined	O
(	O
50	O
μl	O
),	O
lower	O
sensitivity	O
of	O
microscopy	O
and	O
the	O
possible	O
low	O
burden	O
of	O
viable	O
cysts	B-DS
in	O
tissue	O
of	O
camels	B-OG
[	O
13	O
].	O

Even	O
though	O
detection	O
of	O
brain	O
cysts	B-DS
was	O
not	O
possible	O
,	O
manifestations	O
of	O
tachypnoea	O
and	O
neurological	O
signs	O
by	O
a	O
mouse	B-OG
on	O
day	O
20	O
post	O
-	O
inoculation	O
might	O
indicate	O
the	O
more	O
virulent	O
nature	O
of	O
the	O
strain	O
[	O
13	O
].	O

The	O
death	O
of	O
mice	B-OG
in	O
less	O
than	O
3	O
days	O
following	O
i	O
.	O
p	O
.	O
inoculation	O
was	O
attributed	O
to	O
septic	B-DS
peritonitis	I-DS
that	O
resulted	O
from	O
bacterial	O
contamination	O
of	O
isolates	O
or	O
unintended	O
puncturing	O
of	O
the	O
intestine	O
or	O
other	O
vital	O
organs	O
[	O
34	O
].	O

Comparison	O
of	O
seroprevalence	O
results	O
of	O
DAT	O
and	O
ELISA	O

Comparison	O
of	O
the	O
diagnosis	O
of	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
of	O
camels	B-OG
by	O
DAT	O
and	O
ELISA	O
showed	O
moderate	O
agreement	O
(	O
Kappa	O
=	O
0	O
.	O
41	O
,	O
P	O
<	O
0	O
.	O
0001	O
).	O

We	O
think	O
that	O
the	O
discrepancies	O
between	O
the	O
results	O
of	O
DAT	O
and	O
ELISA	O
might	O
be	O
ascribed	O
to	O
the	O
difference	O
in	O
the	O
sensitivity	O
and	O
specificity	O
of	O
the	O
tests	O
in	O
camel	B-OG
.	O

DAT	O
is	O
more	O
sensitive	O
than	O
ELISA	O
which	O
is	O
in	O
accordance	O
with	O
findings	O
of	O
Dubey	O
[	O
58	O
]	O
and	O
Shaapan	O
et	O
al	O
.	O
[	O
59	O
]	O
who	O
reported	O
DAT	O
as	O
the	O
most	O
sensitive	O
test	O
among	O
all	O
serological	O
tests	O
.	O

It	O
has	O
also	O
been	O
reported	O
that	O
test	O
performances	O
may	O
vary	O
when	O
applied	O
on	O
different	O
animal	B-OG
species	O
[	O
60	O
].	O

For	O
example	O
,	O
as	O
opposed	O
to	O
our	O
finding	O
,	O
Zhu	O
et	O
al	O
.	O
[	O
61	O
]	O
from	O
Beijing	O
,	O
China	O
,	O
reported	O
significantly	O
high	O
T	B-OG
.	I-OG
gondii	I-OG
seroprevalence	O
by	O
ELISA	O
(	O
34	O
.	O
7	O
%)	O
as	O
compared	O
to	O
DAT	O
(	O
23	O
.	O
1	O
%,	O
cut	O
-	O
off	O
:	O
1	O
:	O
25	O
)	O
in	O
dogs	B-OG
(	O
high	O
degree	O
of	O
agreement	O
,	O
Kappa	O
=	O
0	O
.	O
644	O
),	O
while	O
no	O
significant	O
difference	O
between	O
the	O
two	O
tests	O
was	O
reported	O
in	O
the	O
case	O
of	O
cats	B-OG
.	O

The	O
P30	B-GP
ELISA	O
test	O
we	O
used	O
in	O
the	O
current	O
study	O
employs	O
non	O
-	O
species	O
specific	O
conjugate	O
and	O
was	O
recommended	O
by	O
the	O
manufacturer	O
to	O
detect	O
anti	O
-	O
T	B-OG
.	I-OG
gondii	I-OG
antibodies	B-GP
in	O
ruminant	B-OG
,	O
cat	B-OG
or	O
pig	B-OG
sera	O
,	O
plasma	O
or	O
meat	O
juice	O
.	O

However	O
,	O
literature	O
with	O
regards	O
to	O
validation	O
of	O
this	O
kit	O
for	O
camels	B-OG
was	O
not	O
accessible	O
;	O
consequently	O
comparison	O
of	O
our	O
results	O
with	O
others	O
couldn	O
’	O
t	O
be	O
made	O
possible	O
.	O

Nevertheless	O
,	O
isolation	O
of	O
viable	O
cysts	B-DS
from	O
four	O
of	O
five	O
camels	B-OG
positive	O
by	O
ELISA	O
(	O
out	O
of	O
ten	O
camel	B-OG
tissues	O
positive	O
by	O
bioassay	O
using	O
DAT	O
,	O
seven	O
were	O
also	O
ELISA	O
positive	O
)	O
coupled	O
with	O
the	O
relatively	O
higher	O
specificity	O
(	O
79	O
.	O
83	O
%)	O
and	O
PPV	O
(	O
73	O
.	O
74	O
%)	O
of	O
ELISA	O
in	O
the	O
present	O
study	O
,	O
suggests	O
the	O
usefulness	O
of	O
the	O
P30	B-GP
ELISA	O
test	O
in	O
epidemiological	O
studies	O
of	O
camel	B-OG
toxoplasmosis	B-DS
particularly	O
among	O
highly	O
disease	O
prevalent	O
populations	O
and	O
in	O
instances	O
of	O
abortion	O
storms	O
[	O
62	O
].	O

Although	O
in	O
the	O
present	O
study	O
DAT	O
is	O
more	O
sensitive	O
than	O
ELISA	O
,	O
the	O
subjective	O
nature	O
and	O
longer	O
waiting	O
time	O
before	O
reading	O
the	O
results	O
might	O
limit	O
widespread	O
and	O
large	O
scale	O
usage	O
of	O
DAT	O
for	O
epidemiological	O
studies	O
[	O
61	O
].	O

Camel	B-OG
owners	O
’	O
food	O
habit	O
and	O
awareness	O
about	O
toxoplasmosis	B-DS

From	O
the	O
questionnaire	O
data	O
it	O
was	O
evident	O
that	O
all	O
of	O
the	O
respondents	O
were	O
uneducated	O
and	O
have	O
a	O
very	O
poor	O
knowledge	O
of	O
T	B-OG
.	I-OG
gondii	I-OG
and	O
its	O
mode	O
of	O
transmission	O
between	O
animals	B-OG
,	O
to	O
humans	B-OG
and	O
the	O
role	O
of	O
felids	B-OG
in	O
the	O
epidemiology	O
of	O
the	O
disease	O
.	O

The	O
lack	O
of	O
knowledge	O
about	O
the	O
disease	O
is	O
one	O
of	O
the	O
main	O
risk	O
factors	O
exposing	O
individuals	O
to	O
the	O
disease	O
,	O
as	O
all	O
of	O
them	O
drink	O
raw	O
camel	B-OG
milk	O
and	O
32	O
.	O
3	O
%	O
responded	O
that	O
they	O
eat	O
either	O
cooked	O
or	O
raw	O
camel	B-OG
meat	O
.	O

Human	B-OG
cases	O
of	O
toxoplasmosis	B-DS
have	O
previously	O
been	O
linked	O
directly	O
to	O
the	O
consumption	O
of	O
raw	O
goat	B-OG
’	O
s	O
milk	O
[	O
63	O
]	O
and	O
camel	B-OG
milk	O
[	O
8	O
].	O

Recently	O
,	O
T	B-OG
.	I-OG
gondii	I-OG
tachyzoites	O
have	O
been	O
detected	O
from	O
milk	O
of	O
naturally	O
infected	O
camels	B-OG
in	O
Iran	O
using	O
ELISA	O
,	O
PCR	O
,	O
cell	O
culture	O
and	O
cat	B-OG
bioassay	O
[	O
10	O
]	O
and	O
from	O
experimentally	O
infected	O
camels	B-OG
in	O
Sudan	O
[	O
64	O
].	O

The	O
high	O
seropositivity	O
and	O
moderately	O
high	O
rate	O
of	O
isolation	O
of	O
viable	O
tissue	O
cysts	B-DS
from	O
edible	O
organs	O
in	O
the	O
current	O
study	O
might	O
be	O
of	O
great	O
public	O
health	O
significance	O
.	O

This	O
is	O
due	O
to	O
the	O
deep	O
rooted	O
habit	O
of	O
consumption	O
of	O
raw	O
camel	B-OG
milk	O
,	O
offal	O
(	O
liver	O
)	O
and	O
to	O
a	O
lesser	O
extent	O
,	O
meat	O
by	O
the	O
pastoral	O
communities	O
of	O
the	O
study	O
area	O
.	O

Moreover	O
,	O
the	O
absence	O
of	O
precautions	O
in	O
handling	O
aborted	O
materials	O
and	O
poor	O
knowledge	O
of	O
pastoralists	O
about	O
toxoplasmosis	B-DS
and	O
the	O
role	O
of	O
cats	B-OG
in	O
the	O
transmission	O
of	O
the	O
disease	O
are	O
additional	O
suggestive	O
evidences	O
for	O
the	O
spread	O
of	O
toxoplasmosis	B-DS
to	O
humans	B-OG
and	O
among	O
camels	B-OG
in	O
the	O
study	O
district	O
.	O

In	O
the	O
absence	O
of	O
a	O
vaccine	O
for	O
camels	B-OG
and	O
the	O
difficulty	O
in	O
changing	O
the	O
pastoral	O
extensive	O
livestock	O
management	O
system	O
to	O
intensive	O
management	O
to	O
reduce	O
the	O
prevalence	O
of	O
the	O
disease	O
,	O
prevention	O
of	O
the	O
disease	O
through	O
education	O
of	O
pastoralists	O
remains	O
a	O
better	O
alternative	O
and	O
perhaps	O
a	O
more	O
economically	O
feasible	O
option	O
to	O
combat	O
the	O
disease	O
.	O

The	O
limitations	O
of	O
the	O
current	O
study	O
include	O
interviewee	O
recall	O
bias	O
,	O
the	O
relatively	O
small	O
number	O
of	O
camels	B-OG
considered	O
for	O
bioassay	O
and	O
the	O
inability	O
to	O
genotype	O
the	O
isolates	O
due	O
to	O
a	O
shortage	O
of	O
resources	O
.	O

Further	O
studies	O
to	O
improve	O
the	O
sensitivity	O
and	O
specificity	O
of	O
ELISA	O
for	O
diagnosis	O
of	O
toxoplasmosis	B-DS
in	O
camels	B-OG
are	O
required	O
.	O

Conclusions	O

T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
of	O
camels	B-OG
in	O
the	O
study	O
district	O
is	O
widespread	O
.	O

Age	O
,	O
presence	O
of	O
domestic	O
cats	B-OG
and	O
study	O
PA	O
are	O
independent	O
predictors	O
of	O
T	B-OG
.	I-OG
gondii	I-OG
seropositivity	O
.	O

Isolation	O
of	O
viable	O
parasites	O
from	O
edible	O
tissues	O
of	O
camels	B-OG
and	O
the	O
very	O
poor	O
knowledge	O
of	O
pastoralists	O
about	O
toxoplasmosis	B-DS
,	O
suggest	O
that	O
people	O
are	O
at	O
a	O
higher	O
risk	O
of	O
acquiring	O
T	B-DS
.	I-DS
gondii	I-DS
infection	I-DS
.	O

Therefore	O
,	O
prevention	O
of	O
toxoplasmosis	B-DS
through	O
biosecurity	O
measures	O
,	O
education	O
of	O
pastoralists	O
about	O
the	O
identified	O
risks	O
and	O
further	O
investigation	O
to	O
unravel	O
the	O
economic	O
and	O
public	O
health	O
implications	O
of	O
the	O
high	O
prevalence	O
of	O
T	B-OG
.	I-OG
gondii	I-OG
in	O
the	O
area	O
deserves	O
consideration	O
.	O

containing	O
results	O
of	O
analysis	O
based	O
on	O
ELISA	O
for	O
animal	B-OG
level	O
seroprevalence	O
,	O
Table	O
S2	O
.	O
herd	O
level	O
seroprevalence	O
and	O
Table	O
S3	O
.	O
logistic	O
regression	O
analysis	O
of	O
predictors	O
of	O
seropositivity	O
.	O

Competing	O
interests	O

The	O
authors	O
declare	O
that	O
they	O
have	O
no	O
competing	O
interests	O
.	O

Authors	O
’	O
contribution	O

EZG	O
conceived	O
and	O
designed	O
the	O
proposal	O
,	O
participated	O
in	O
the	O
coordination	O
and	O
management	O
of	O
the	O
study	O
,	O
collected	O
,	O
tested	O
and	O
analyzed	O
the	O
data	O
and	O
drafted	O
the	O
article	O
.	O

HAY	O
participated	O
in	O
sample	O
collection	O
,	O
laboratory	O
testing	O
and	O
drafting	O
of	O
article	O
with	O
inputs	O
from	O
GT	O
,	O
GT	O
and	O
FD	O
.	O

TST	O
,	O
MV	O
and	O
V	O
di	O
M	O
participated	O
in	O
the	O
study	O
design	O
and	O
edition	O
of	O
article	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

